Short-Acting Beta-Agonist Research: A Perspective
Asthma mortality increased sharply in New Zealand in 1977, prompting a national investigation into circumstances of asthma deaths. Subsequent observations of improved asthma control in subjects withdrawn from regular beta2-agonist treatment raised the question of whether asthma severity and, therefo...
Saved in:
Main Author: | Malcolm R Sears |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2001-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2001/987151 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perceptions, practices, and experiences of asthma patients and community pharmacists on short-acting beta-2 agonists inhaler use: A qualitative study
by: Rabia Hussain, et al.
Published: (2025-12-01) -
Short-acting beta agonist, antibiotics, oral corticosteroid and association with mortality and cardiopulmonary events in patients with COPD: a retrospective cohort study in Alberta, Canada
by: Mohit Bhutani, et al.
Published: (2025-01-01) -
Unveiling the amplified oxidase-mimetic activity of MnCoO nanosheets for the ultra-sensitive determination of the long-acting beta-adrenoceptor agonist indacaterol
by: Amal A. El-Masry, et al.
Published: (2025-08-01) -
Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)
by: Paul K Keith, et al.
Published: (2009-01-01) -
Characterization of LY3324954 a long-acting glucagon-receptor agonist
by: William Roell, et al.
Published: (2025-01-01)